Figure 7

Drug sensitivity evaluation of the mtPCD-related prognostic signature. (A) Analyze the relationship between drug IC50 values and mtPCD risk score, and identify 13 candidate drugs. (B, C) Comparison of drug sensitivity between low-risk and high-risk groups in the TCGA-BLCA cohort.